TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway

被引:34
作者
Wang, Jun [1 ]
Ferreira, Ricardo [2 ]
Lu, Wanhua [1 ]
Farrow, Samatha [3 ]
Downes, Kate [3 ]
Jermutus, Lutz [4 ]
Minter, Ralph [4 ]
Al-Lamki, Rafia S. [1 ]
Pober, Jordan S. [5 ]
Bradley, John R. [1 ]
机构
[1] Univ Cambridge, Dept Med, NIHR Cambridge Biomed Res Ctr, Cambridge, England
[2] Univ Oxford, Wellcome Ctr Human Genet, JDRF Wellcome Diabet & Inflammat Lab, Oxford, England
[3] Univ Cambridge, Dept Haematol, Cambridge, England
[4] MedImmune Ltd, Granta Pk, Cambridge CB21 6GH, England
[5] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
关键词
TUMOR-NECROSIS-FACTOR; ALPHA; FOXP3; RECEPTOR;
D O I
10.1038/s41598-018-30621-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human T regulatory cells (T regs) express high levels of TNF receptor 2 (TNFR2). Ligation of TNFR2 with TNF, which can recognise both TNFR1 and TNFR2, or with a TNFR2-selective binding molecule, DARP in 18 (D18) activates canonical NF-KB signalling, assessed by hcBoi degradation, and the magnitude of the response correlates with the level of TNFR2 expression. RNA-seq analysis of TNF- or D18-treated human T regs revealed that TNFR2 ligation induces transcription of NFKB2 and RELB, encoding proteins that form the non-canonical NF-KB transcription factor. In combination with IL2, D18 treatment is specific for T regs in (1) stabilising NF-kappa B-inducing kinase protein, the activator of non-canonical NF-kappa B signalling, (2) inducing translocation of ReIB from cytosol to nucleus, (3) increasing cell cycle entry, and (4) increasing cell numbers. However, the regulatory function of the expanded T regs is unaltered. Inhibition of ReIB nuclear translocation blocks the proliferative response. We conclude that ligation of TNFR2 by D18 enhances IL2-induced T regs proliferation and expansion in cell number through the non-canonical NF-kappa B pathway.
引用
收藏
页数:11
相关论文
共 29 条
[1]   Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma [J].
Al-Lamki, Rafia S. ;
Wang, Jun ;
Yang, Jun ;
Burrows, Natalie ;
Maxwell, Patrick H. ;
Eisen, Timothy ;
Warren, Anne Y. ;
Vanharanta, Sakari ;
Pacey, Simon ;
Vandenabeele, Peter ;
Pober, Jordan S. ;
Bradley, John R. .
ONCOTARGET, 2016, 7 (17) :24111-24124
[2]   TNFR1-and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury [J].
Al-Lamki, RS ;
Wang, J ;
Vandenabeele, P ;
Bradley, JA ;
Thiru, S ;
Luo, DH ;
Min, W ;
Pober, JS ;
Bradley, JR .
FASEB JOURNAL, 2005, 19 (12) :1637-1645
[3]   Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human [J].
Birzele, Fabian ;
Fauti, Tanja ;
Stahl, Heiko ;
Lenter, Martin C. ;
Simon, Eric ;
Knebel, Dagmar ;
Weith, Andreas ;
Hildebrandt, Tobias ;
Mennerich, Detlev .
NUCLEIC ACIDS RESEARCH, 2011, 39 (18) :7946-7960
[4]   Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells [J].
Chen, Xin ;
Baeumel, Monika ;
Maennel, Daniela N. ;
Howard, O. M. Zack ;
Oppenheim, Joost J. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (01) :154-161
[5]   TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment [J].
Chen, Xin ;
Wu, Xueqiang ;
Zhou, Qiong ;
Howard, O. M. Zack ;
Netea, Mihai G. ;
Oppenheim, Joost J. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (03) :1076-1084
[6]   Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion [J].
Chopra, Martin ;
Biehl, Marlene ;
Steinfatt, Tim ;
Brandl, Andreas ;
Kums, Juliane ;
Amich, Jorge ;
Vaeth, Martin ;
Kuen, Janina ;
Holtappels, Rafaela ;
Podlech, Juergen ;
Mottok, Anja ;
Kraus, Sabrina ;
Jordan-Garrote, Ana-Laura ;
Baeuerlein, Carina A. ;
Brede, Christian ;
Ribechini, Eliana ;
Fick, Andrea ;
Seher, Axel ;
Polz, Johannes ;
Ottmueller, Katja J. ;
Baker, Jeanette ;
Nishikii, Hidekazu ;
Ritz, Miriam ;
Mattenheimer, Katharina ;
Schwinn, Stefanie ;
Winter, Thorsten ;
Schaefer, Viktoria ;
Krappmann, Sven ;
Einsele, Hermann ;
Mueller, Thomas D. ;
Reddehase, Matthias J. ;
Lutz, Manfred B. ;
Maennel, Daniela N. ;
Berberich-Siebelt, Friederike ;
Wajant, Harald ;
Beilhack, Andreas .
JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (09) :1881-1900
[7]   A Common Haplotype of the TNF Receptor 2 Gene Modulates Endotoxin Tolerance [J].
Fairfax, Benjamin P. ;
Davenport, Emma E. ;
Makino, Seiko ;
Hill, Adrian V. S. ;
Vannberg, Fredrik O. ;
Knight, Julian C. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (05) :3058-3065
[8]   IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients [J].
Ferreira, Ricardo C. ;
Simons, Henry Z. ;
Thompson, Whitney S. ;
Cutler, Antony J. ;
Dopico, Xaquin Castro ;
Smyth, Deborah J. ;
Mashar, Meghavi ;
Schuilenburg, Helen ;
Walker, Neil M. ;
Dunger, David B. ;
Wallace, Chris ;
Todd, John A. ;
Wicker, Linda S. ;
Pekalski, Marcin L. .
DIABETOLOGIA, 2015, 58 (04) :781-790
[9]   Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo [J].
Gavin, MA ;
Clarke, SR ;
Negrou, E ;
Gallegos, A ;
Rudensky, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :33-41
[10]   The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor [J].
Grell, M ;
Wajant, H ;
Zimmermann, G ;
Scheurich, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :570-575